Stanley Yu
About Stanley Yu
Stanley Yu is a Senior Principal Scientist in CMC Analytical Development at Mirati Therapeutics, where he has worked since 2022. He has extensive experience in analytical development and purification processes, having previously held positions at Neurocrine Biosciences and American Peptide Company.
Work at Mirati Therapeutics
Stanley Yu has been employed at Mirati Therapeutics as a Senior Principal Scientist in CMC Analytical Development since 2022. His role involves overseeing analytical development processes and ensuring compliance with cGMP standards. He operates from the San Diego, California location, contributing to the company's mission of advancing innovative therapies.
Previous Experience at Neurocrine Biosciences
Prior to joining Mirati Therapeutics, Stanley Yu worked at Neurocrine Biosciences in various capacities. He served as a Principal Scientist in CMC Analytical Development from 2020 to 2022 and held the position of Senior Scientist in the same department from 2018 to 2020. He began his tenure at Neurocrine as a Scientist in CMC Analytical Development from 2016 to 2018, gaining extensive experience in analytical methodologies and product development.
Professional Background in Purification Chemistry
Stanley Yu has a strong background in purification chemistry, having developed and facilitated large-scale purifications of cGMP products at American Peptide Company. He authored and updated standard operating procedures (SOPs), master batch records (MBRs), and other related cGMP documentation while working as a Purification Chemist at the same company. This experience provided him with a solid foundation in regulatory compliance and quality assurance.
Education and Expertise
Stanley Yu earned a Bachelor of Science degree in Biochemistry from the University of California, Los Angeles (UCLA), where he studied from 2007 to 2011. His educational background has equipped him with a comprehensive understanding of biochemical principles, which he applies in his roles within the pharmaceutical industry.
Analytical Research Support at Takeda California
In addition to his roles at Mirati Therapeutics and Neurocrine Biosciences, Stanley Yu provided analytical research support at Takeda California. His responsibilities included compound purifications, method screenings, purity and potency assessments, and compound structure elucidations. This experience further enhanced his analytical skills and contributed to his expertise in the field.